Table 1. Sample types and numbers stored at baseline and at year 3.
| (a) BASELINE TIMEPOINT | ||||||||
| 500 μL aliquots | 250 μL aliquots | All aliquots | ||||||
| Sample Type | No. Pts | Total | Av/pt | Total | Av/pt | Total | Av/pt | Target /pt |
| EDTA Plasma | 11,985 | 225,095 | 18 | 108,390 | 9 | 333,485 | 27 | 28 |
| NaC Plasma | 11,820 | 11,137 | 1 | 103,415 | 8 | 114,542 | 9 | 10 |
| SST Serum | 12,011 | 43,341 | 4 | 75,600 | 6 | 118,931 | 10 | 10 |
| RBC | 11,980 | 47,881 | 4 | - | - | 47,881 | 4 | 4 |
| Urine | 12,021 | 71,807 | 6 | - | - | 71,807 | 6 | 6 |
| Buffy coat | 11,985 | 71,815 | 6 | - | - | 71,815 | 6 | 6 |
| Total | 12,219 | 471,076 | 39 | 287,405 | 23 | 758,481 | 62 | 64 |
| (b) YEAR 3 TIMEPOINT | ||||||||
| 500 μL aliquots | 250 μL aliquots | All aliquots | ||||||
| Sample Type | No. Pts | Total | Av/pt | Total | Av/pt | Total | Av/pt | Target /pt |
| EDTA Plasma | 10,371 | 194,086 | 18 | 96,099 | 9 | 290,185 | 27 | 28 |
| NaC Plasma | 10,230 | 6,727 | 1 | 91,657 | 9 | 98,384 | 9 | 10 |
| SST Serum | 10,373 | 37,516 | 4 | 65,632 | 6 | 103,148 | 10 | 10 |
| RBC | 10,356 | 41,628 | 4 | - | - | 41,628 | 4 | 4 |
| Urine | 10,225 | 61,340 | 6 | - | - | 61,340 | 6 | 6 |
| Buffy coat | 10,368 | 41,732 | 4 | - | - | 41,732 | 4 | 4 |
| Total | 10,617 | 341,297 | 37 | 295,120 | 24 | 636,417 | 60 | 62 |
This table shows the number of participants with at least 1 aliquot of each sample type; Av/pt columns display the average number of aliquots of each sample type, to the nearest whole number, across the entire Biobank cohort of participants with stored blood and/or urine at (a) baseline (12,219) or (b) year 3 (10,617). Target/pt is the maximum number of tube types per participant’s collection. Total No. Pts is the number of participants with blood or urine components stored. EDTA = ethylenediaminetetraacetic acid, NaC = sodium citrate, SST = serum separator tube, RBC = packed red blood cells.